Si-Bone (SIBN) Long-Term Investments (2019 - 2020)

Si-Bone (SIBN) recorded quarterly Long-Term Investments of $1.3 million in Q1 2020, little changed quarter-over-quarter from $1.3 million in Q4 2019.

Si-Bone (SIBN) Long-Term Investments (2019 - 2020) Analysis & Trends

Si-Bone's Long-Term Investments history runs 2 years deep, the most recent figure standing at $1.3 million for Q1 2020.

In Q1 2020, Long-Term Investments changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2020 stood at $1.3 million (changed N/A YoY), while the FY2019 annual figure was $1.3 million, changed N/A from the prior year.
Long-Term Investments was $1.3 million for Q1 2020 at Si-Bone, roughly flat from $1.3 million in the prior quarter.
In the past five years, Long-Term Investments ranged from a high of $5.3 million in Q3 2019 to a low of $1.3 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	1.09 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	285.60 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	166.25 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Si-Bone	696.98 Mn	556.86 Mn	41.94 Mn	-

Download Data